An extract of the red alga,
Neorhodomela aculeata,
exhibited antiviral activity against human rhinoviruses. Bioassay-guided purification was performed to yield six compounds, which were subsequently identified as lanosol (
1) and five polybromocatechols (
2–
6) by spectroscopic methods,
[...] Read more.
An extract of the red alga,
Neorhodomela aculeata,
exhibited antiviral activity against human rhinoviruses. Bioassay-guided purification was performed to yield six compounds, which were subsequently identified as lanosol (
1) and five polybromocatechols (
2–
6) by spectroscopic methods, including 1D and 2D NMR and mass spectrometric analyses. Structurally, all of these compounds, except compound
5, contain one or two 2,3-dibromo-4,5-dihydroxyphenyl moieties. In a biological activity assay, compound
1 was found to possess antiviral activity with a 50% inhibitory concentration (IC
50) of 2.50 μg/mL against HRV2. Compound
3 showed anti-HRV2 activity, with an IC
50 of 7.11 μg/mL, and anti-HRV3 activity, with an IC
50 of 4.69 μg/mL, without demonstrable cytotoxicity at a concentration of 20 μg/mL. Collectively, the results suggest that compounds
1 and
3 are candidates for novel therapeutics against two different groups of human rhinovirus.
Full article